Literature DB >> 20599590

A substance P mediated pathway contributes to 6-hydroxydopamine induced cell death.

Emma Thornton1, Tuyet T B Tran, Robert Vink.   

Abstract

The neurotoxin 6-hydroxydopamine (6-OHDA) is used to induce dopaminergic cell death, resulting in insufficient striatal dopamine content in the basal ganglia and motor dysfunction typical of Parkinson's disease. Dopamine induces release of the neuropeptide substance P (SP) within the substantia nigra, whereas SP is able to potentiate striatal dopamine release, thus creating a positive feedback mechanism. Previous studies, however, have shown that elevated SP is detrimental to neuronal survival and motor function in acute brain injury. In the current study, we demonstrate that 6-OHDA increases SP production in meso-striatal organotypic co-culture. Moreover, there was a significant correlation between SP content and lactate dehydrogenase release, a marker of cell death, suggesting elevated SP production may contribute to 6-OHDA induced cell death in vitro. 2010. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599590     DOI: 10.1016/j.neulet.2010.06.057

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

2.  Substance P promotes the progression of bronchial asthma through activating the PI3K/AKT/NF-κB pathway mediated cellular inflammation and pyroptotic cell death in bronchial epithelial cells.

Authors:  Miao Li; Xiao Zhong; Wen-Ting Xu
Journal:  Cell Cycle       Date:  2022-06-26       Impact factor: 5.173

Review 3.  Demystifying the Neuroprotective Role of Neuropeptides in Parkinson's Disease: A Newfangled and Eloquent Therapeutic Perspective.

Authors:  Tapan Behl; Piyush Madaan; Aayush Sehgal; Sukhbir Singh; Hafiz A Makeen; Mohammed Albratty; Hassan A Alhazmi; Abdulkarim M Meraya; Simona Bungau
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

4.  Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.

Authors:  Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

5.  Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study.

Authors:  Cui-Tao Lu; Rong-Rong Jin; Yi-Na Jiang; Qian Lin; Wen-Ze Yu; Kai-Li Mao; Fu-Rong Tian; Ya-Ping Zhao; Ying-Zheng Zhao
Journal:  Drug Des Devel Ther       Date:  2015-04-07       Impact factor: 4.162

6.  Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.

Authors:  Ying-Zheng Zhao; Rong-Rong Jin; Wei Yang; Qi Xiang; Wen-Ze Yu; Qian Lin; Fu-Rong Tian; Kai-Li Mao; Chuan-Zhu Lv; Yi-Xiáng J Wáng; Cui-Tao Lu
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

Review 7.  Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.

Authors:  Duraisamy Kempuraj; Ramasamy Thangavel; Govindhasamy P Selvakumar; Smita Zaheer; Mohammad E Ahmed; Sudhanshu P Raikwar; Haris Zahoor; Daniyal Saeed; Prashant A Natteru; Shankar Iyer; Asgar Zaheer
Journal:  Front Cell Neurosci       Date:  2017-07-24       Impact factor: 5.505

8.  Selenium reduces nociceptive response in acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity.

Authors:  Patrick Oluwole Abolarin; Abdulrazaq Bidemi Nafiu; Aboyeji Lukuman Oyewole; Abdulbasit Amin; Olalekan Michael Ogundele; Bamidele Victor Owoyele
Journal:  IBRO Neurosci Rep       Date:  2021-11-27

9.  A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease.

Authors:  Vignayanandam Ravindernath-Jayashree Muddapu; Karthik Vijayakumar; Keerthiga Ramakrishnan; V Srinivasa Chakravarthy
Journal:  Front Neurosci       Date:  2022-04-19       Impact factor: 5.152

10.  Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson's disease.

Authors:  Emma Thornton; Robert Vink
Journal:  Neural Regen Res       Date:  2015-09       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.